Pestalozzi advises global institutional investors in connection with up to $ 44,000,000 equity linked investment in WISeKey International Holding listed at SIX Swiss Exchange and with ADS traded at Nasdaq. The investment is structured in two convertible note subscription agreements and relevant warrant agreements. The Pestalozzi team was led by Christian Leuenberger (lead partner – […]
Dermavant Sciences, a clinically focused biopharmaceutical company dedicated to developing and commercializing innovative therapies in the field of immune dermatology, has signed a $160 million revenue interest purchase and sale agreement with three participants for its
Anapaya Systems, the commercial provider of SCION technology, has secured CHF 6.8 million in funding with lead investor SIX Fintech Ventures, the corporate venture arm of SIX. Bär & Karrer acted as legal advisor to
Glarner Kantonalbank (GLKB) has successfully placed a CHF 150 million Tier 2 bond. The coupon has been fixed at 1.00% with an issue price of 100.353%. It is a 10-year bond with a one-time termination option by GLKB after 5
Zurich-based Imburse, a cloud based payments integration platform provider, has announced the completion of a USD 12 million Series A funding round lead by partners of DST Global, followed by existing investors Addition, Lakestar, Guidewire Software,
Baker McKenzie has advised a large Swiss family office on a USD 150 million art financing transaction. The financing is documented under a Swiss law governed facility agreement and takes the form of a committed term
The Six Swiss Exchange listed Tecan Group entered into an agreement to acquire US-based Paramit Corporation for a total purchase consideration of USD 1.0 billion. Paramit, headquartered in Morgan Hill (California/USA), is a leading OEM
The City of Zurich successfully issued CHF 150 million 0.00% senior bonds due 2030. The issuance is documented in a prospectus that is fully compliant with the Financial Services Act. Homburger acted as transaction counsel with respect to
One Swiss Bank and its shareholders entered into a merger agreement with Banque Profil de Gestion, which closed on June 1, 2021 following the grant of the necessary authorizations and the fulfilment of other conditions precedent pursuant
Swiss Nuclides, a developer of novel radionuclide Pet tracers for the precision diagnostics, has closed the first tranche of its series A financing round, raising CHF 2.6 million from private investors. Vischer has been acting as
